How would you treat a patient with EGFR+ oligo-metastatic lung adenocarcinoma status post resection of the primary and metastatic sites?

Would you give adjuvant chemotherapy or start osimertinib?

Community PollStarted

How would you treat a patient with EGFR mutant oligo-metastatic lung adenocarcinoma s/p resection of both the primary and metastatic sites?

98 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer

Mednet MemberInvited Expert

Medical Oncology · Wexner Medical Center at The Ohio State University

Answered on

This is a somewhat challenging question - on the one hand, the patient has metastatic (albeit "oligo" metastatic) cancer and systemic treatment with osimertinib is clearly indicated and appropriate for metastatic EGFR mutant lung cancers. On the other hand, all known disease has been resected, and t...

Join for free or sign in to see the full answer